ICU Medical, Inc. Expands Its Relationship With MedAssets Supply Chain Systems by Signing Two New Contracts for Critical Care Products Including a Next Generation SELECT Agreement


SAN CLEMENTE, Calif., Nov. 17, 2009 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a leading low cost manufacturer of safe medical connectors, custom medical products and critical care devices, today announced that it has entered into contracts for Invasive Hemodynamic monitoring products with MedAssets Supply Chain Systems. MedAssets Supply Chain Systems is one of the nation's largest group purchasing organizations (GPO), providing innovative solutions for healthcare providers to improve their margins and cash flow. These contracts offer MedAssets' customers ICU Medical's leading line of Disposable Transducers, Thermodilution Catheters and In-Line Blood Sampling devices which provide better patient outcomes and cost reduction as well as cost avoidance.

Dr. Lopez, ICU Medical's President and CEO, stated, "We are excited to expand our relationship with MedAssets and their members. Our partnership in the Critical Care arena will address both the clinical and financial issues in today's complex marketplace as well as strengthen our overall position within MedAssets as a leading solution provider. This is truly a win-win for ICU Medical, MedAssets, and all its members."

Under the terms of the agreement, MedAssets will offer its GPO customers ICU Medical's contracted products for a minimum of three years, through December 31, 2012. The two companies will also collaborate on customized marketing and sales programs designed to bring significant value to MedAssets customers.

"ICU Medical has been a long-standing contracted vendor with MedAssets, and we are very pleased with their product portfolio and overall value they offer our customers," said Mark Miriani, President of MedAssets Supply Chain Systems. "Our focus remains to provide products to our customers that allow them to offer the best patient and employee safety, overall quality and cost savings. ICU Medical is a great example of a contracted supplier that helps us to achieve these goals."

About MedAssets Supply Chain Systems

MedAssets Supply Chain Systems is one of the largest group purchasing organizations in the U.S., utilizing a national contract portfolio of over 1,500 contracts to efficiently connect manufacturers, distributors and other suppliers with its more than 1,700 hospitals and over 30,000 non-acute healthcare provider customers. MedAssets Supply Chain Systems is a wholly owned subsidiary of MedAssets, Inc. For more information, visit www.medassets.com.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) is a leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications. Our devices are designed to protect patients from catheter related bloodstream infections and healthcare workers from exposure to infectious diseases through accidental needlesticks. We are also a leader in the production of custom I.V. systems and we incorporate our proprietary products into many of those custom I.V. systems. For more information, visit www.icumed.com.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as "will," "expect," "believe," "could," "would," "estimate," "continue," "build," "expand" or the negative thereof or comparable terminology, and may include (without limitation) information regarding the Company's expectations and goals or intentions regarding the future, including without limitation, its collaborative efforts and ongoing relationship with MedAssets and future product sales. In particular, there can be no assurances that these agreements will result in significant sales of ICU Medical's critical care products. These forward-looking statements are based on Management's current expectations, estimates, forecasts and projections about the Company and assumptions Management believes are reasonable, all of which are subject to risks and uncertainties that could cause actual results and events to differ materially from those stated in the forward-looking statements. These risks and uncertainties include, but are not limited to: growing demand for our products, investments in strategic growth and research, continued growth and improving efficiencies. Future results are subject to risks and uncertainties, including the risk factors, and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission, which include those in the Form 10-K for the year ended December 31, 2008 and 10-Q for the quarter ended September 30, 2009. Forward-looking statements contained in this press release are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.



            

Contact Data